The Effect of Transdermal Nitroglycerin on Pain Control in Diabetic Patients With Peripheral Neuropathy Publisher



Taheri A¹ ; Farbood A^{2, 7, 8} ; Heshmat R³ ; Samadi A¹ ; Khashayar P⁴ ; Qorbani M⁵ ; Ghorbani M² ; Ebrahimi Khaneqah G⁶
Source: Journal of Diabetes and Metabolic Disorders Published:2015

Abstract

Background: Despite high prevalence of diabetic peripheral neuropathy there is no definite treatment for the condition. The present study was conducted to assess the efficacy of transdermal nitroglycerin patch in pain control of patients with DPN. Methods: This randomized, double-blind, crossover study was conducted on 30 patients with symmetric distal peripheral neuropathy and good glycemic control. The patients were randomly assigned to receive nitroglycerin transdermal and placebo patches in two 4-week stages. The severity of pain and other neuropathic sensory symptoms were assessed at the end of each course. Results: Mean reduction of pain severity was more prominent in the NTG group compared to placebo group of the study (p = 0.048) at least during the first phase of the study. Except for mood and sleep, a significant reduction in all Brief Pain Inventory scores was noted in the drug group (all corrected p < 0.05). SF-MPQ also showed the drug patch to be effective in improving different aspects of pain measured using McGill Pain Questionnaire, except for Role-emotional. Conclusions: It could be concluded that nitroglycerin plasters can effectively help alleviate pain in patients with diabetic neuropathy. Trial registration:IRCT201308223213N1 © 2015 Taheri et al.